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Arthroplasty ranks among the greatest achievements of surgical medicine, with total hip
replacement termed “the operation of the century.” Despite its wide success, arthroplasty
bears risks, such as local reactions to implant derived wear and corrosion products.
Prevalence of allergies across Western society increases and along the number of
reported hypersensitivity reactions to orthopedic implant materials. In this context the
main focus is on delayed hypersensitivity (DTH). This mechanism is mainly attributed
to T cells and an overreaction of the adaptive immune system. Arthroplasty implant
materials are in direct contact with bone marrow (BM), which is discussed as a secondary
lymphoid organ. However, the mechanisms of sensitization toward implant wear remain
elusive. Nickel and cobalt ions can form haptens with native peptides to activate
immune cell receptors and are therefore common T helper allergens in cutaneous DTH.
The rising prevalence of metal-related allergy in the general population and evidence
for the immune-modulating function of BM allow for the assumption hypersensitivity
reactions could occur in peri-implant BM. There is evidence that pro-inflammatory
factors released during DTH reactions enhance osteoclast activity and inhibit osteoblast
function, an imbalance characteristic for osteolysis. Even though some mechanisms
are understood, hypersensitivity has remained a diagnosis of exclusion. This review
aims to summarize current views on the pathomechanism of DTH in arthroplasty with
emphasis on BM and discusses recent advances and future directions for basic research
and clinical diagnostics.
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INTRODUCTION
The evolution of immune systems across the plant and animal
kingdom has always been an arms race between pathogen and
host. Mechanisms to evade immune cells or to destroy an invader
have been a fine tuned development over centuries (1). This lead
to distinct lymphoid tissues in mammals, located at potential
exposure sites such as skin, intestine, and pharynx. Despite
these first lines of defense, other designated secondary lymphoid
organs have been discovered, such as lymph nodes and spleen. In
addition, the bone marrow (BM) is discussed to behave as such
(2). Originally named primary lymphoid organ and producer
of stem and all blood cells, the human BM is composed of
monocytes, macrophages, progenitor cells, including progenitor
T cells, developing B cells and mature T and B cells. In fact,
the BM appears to be a major memory T cell niche maintained
over years within the human body (3, 4). There is evidence
that peripheral blood might not be a good representation of the
individual immunological memory after all (5, 6). Memory T
cells in the BM seem to have a higher proliferation rate, can be
activated directly by an antigen and recruit other immune cells,
thereby fostering an immune response (5). Effector memory T
cells are able to migrate into inflamed tissues and further amplify
this pro-inflammatory environment via their effector function,
the recruitment of other immune cells, or a combination of both
(7). Allergies or, more generally, hypersensitivity reactions are
commonly described as an exaggeration of the immune system
and categorized into four distinct types, depending on their
mechanism of action and cells involved. Type I-III responses
are antibody-mediated and differ in their mechanism of antigen
recognition and consequent cell activation, whereas type IV
hypersensitivity is T cell-mediated and an antibody-independent
reaction. In order to avoid confusion with another type IV
characterization, type IV hypersensitivity is termed delayed type
hypersensitivity (DTH) throughout the following text. Whether
allergies or at least metal induced hypersensitivity reactions occur
in the peri-implant tissue is subject to global debate (8), with
arguments currently lacking causal evidence. In hip and knee
arthroplasty the BM, as distinct lymphoid organ, is opened and
foreign bodies, the implant components, are inserted. Implant
components are usually composed of ceramics, polyethylene,
metals, or metal alloys and sometimes fixed with bone cement.
Some of these materials, especially nickel and cobalt, which are
common allergens in cutaneous hypersensitivity (9, 10) have the
capacity to trigger a hypersensitivity reaction or, more precisely,
an allergic reaction and consequently cause inflammation (11).
Histopathological examinations of peri-implant membranes
provide evidence that T cell-mediated DTH is one of the keys to
clinically prevalent pathologies of implant-related inflammatory
reactions (12). This review aspires to summarize current findings
on the immunological capacity of the BM (13) with special
regard to DTH reactions and attempts to connect the dots
with metal implant material hypersensitivity and its prospects
in diagnostics. The aim of this review is to raise awareness
that metal hypersensitivity might occur beyond the peri-implant
membrane and the individual immunological memory has to
be considered.
T CELLS IN HUMAN BONE MARROW
Originally, the BM was solely described as the origin of all
hematopoietic precursor cells, giving rise to lymphocytes to exit
the BM and complete their maturation in the periphery. This idea
has to be revised after finding a niche for memory T cells inside
the BM (14–17).Mature T cells seem tomigrate back to the BM to
reside inside its cavities (4, 18). Progenitor T cells develop, leave
the BM and migrate to the thymus, where they express their T
cell receptor for the first time and get selected for the cytotoxic
or the helper cell lineage by expressing either co-receptor CD8 or
CD4. Once they have passed the negative and positive selection
to exclude auto-reactivity in the thymic tissue; they are released
into the peripheral blood. In case of infection, T cells are activated
in lymphoid organs and tissues such as spleen, lymph nodes,
and Peyer’s patches or at the site of infection. At this specific
reaction site, T helper cells interact with antigen-presenting cells
(APCs) such as dendritic cells to find their cognate antigen to
proliferate and migrate to the site of infection or inflammation,
and stimulate other immune cells such as antibody-producing
B cells. After an inflammation is terminated most T cells die
and only a few home to lymphoid tissues to remain there as
memory T cells. Recent findings suggest the preferred site is the
BM (16). Additionally, the BM has the capacity to host all major
subsets of CD4 and CD8T cells, which include effector, central
memory, effector memory, and terminally differentiated T cells
(17). While effector cells are short-lived, memory T cells survive
over a longer period (6). This allows for the assumption that
these cells could react to antigens derived from metal implants,
especially if memory had been established prior to insertion of a
metallic implant. This could be the case if T cells had been primed
in the periphery and remained “silent” in the BM. Yet, it needs
to be established how local T cell subsets vary among humans.
Naïve T cells and their travel routes through the body are poorly
understood. Whereas reports on naïve T cells being primed in
the BM exist (19, 20), it is unclear if naïve T cells actively migrate
to the BM or just circulate between secondary lymphoid organs
and within the blood (21). If the BM could act as a secondary
lymphoid tissue, naïve T cells could reside there as well or at least
pass through the BM and newly encounter wear particles derived
from the implant. This is a concept that needs investigation, as
there is currently not enough data to support or reject the idea
of such a locally occurring peri-implant DTH reaction. This can
only be a potential mechanism to explain why some individuals
with no known sensitivities prior to surgery develop peri-implant
complications (e.g., implant loosening, joint malfunction despite
correct implant position) or diffuse symptoms that point towards
DTH. A respective study would be of high clinical value but
is not available in current literature. Roughly 2% of the total
lymphocyte numbers are circulating in the periphery compared
to 11% residing in the BM, of which memory T cells constitute
a major part (3, 4, 16, 22). Blood values of T cells can therefore
only be a rough estimate of their total numbers present in the
body (5). Distinct in vitro cultures, such as 3D bone and BM
microfluidic culture systems, could become a valuable tool to
study this effect in more detail. The BM is thought to host many
more memory T cells than are circulating in the peripheral blood,
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possibly rendering the lymphocyte transformation test (LTT),
which is performed with blood T cells, a questionable predictor
for metal hypersensitivity prior to implantation. It must further
be noted that naïve T cells can be primed in the BM in mice (19).
T cells are the main cell type to drive metal-associated delayed
hypersensitivity reactions. Their presence in the BM should be
kept in mind, especially when facing and treating patients with
known allergies and intolerances.
HYPERSENSITIVITY REACTIONS IN
ORTHOPEDICS
Hypersensitivity toward metals is one of the most common
causes for DTH, affecting 15–20% of the Western population
(23, 24) with mainly cutaneous manifestations, such as pruritus
and rashes. Delayed hypersensitivity is commonly described
as a local reaction in which an allergen is recognized by APCs
and presented to a subset of T helper cells (Th1), which leads
to a proper pro-inflammatory response. The trigger substance
can react with self-proteins and form hapten-protein-complexes
which bind to major histocompatibility complexes (MHC)
and activate T cells like a regular foreign antigen (e.g., from
bacteria). The reaction is divided in two phases: sensitization
and elicitation. During sensitization the APCs home to
secondary lymphoid organs and activate T cells. T cells expand
and consequently produce memory T cells which trigger a
stronger and more efficient response upon secondary antigen
encounter. One of the most common forms of DTH is cutaneous
hypersensitivity from inexpensive jewelry containing metal
ions like nickel and cobalt. Nickel ions are known to induce
conformational changes in the protein-MHC class II complex
(25) and activate T cells, which in return release cytokines to
attract macrophages to the site of allergen exposure (26). Nickel
can also bind directly to the T cell receptor like a superantigen
(9). This may be a reason why DTH remains systematically
undetected, considering that the entire inflammatory process
is locally restricted to the peri-implant region. DTH used to be
a term coined by a pathomechanism which always assumes an
externally inhaled, ingested, or absorbed allergen. Even though
allergies to implant materials used in orthopedics are thought
to occur infrequently, metal related pathologies, including peri-
prosthetic osteolysis and aseptic implant loosening, rank among
the most common reasons for surgical revision of arthroplasty
implants (27–30). Whether implant-related hypersensitivity
reactions is the underlying mechanisms has remained largely
unknown. Hypersensitivity reactions induced by implant-
released metals, like cobalt and nickel, have been characterized
via histology, patch testing, and LTT. Issues that likely promote
an underestimation of the prevalence of such allergic reactions
are the lack of reliable and accurate hypersensitivity tests and
a great similarity in clinical presentation with periprosthetic
joint infection (PJI), another major cause of arthroplasty failure,
and with a myriad of other complications in arthroplasty.
Thus, typical signs and symptoms of PJI as well as of
hypersensitivity include local swelling, erythema, warmth,
pain, and functional deficit of the affected joint. Therefore,
arthroplasty implant-related hypersensitivity has remained
a diagnosis of exclusion (31). Appropriate workup must
always be guided by thorough differential diagnostic thinking,
directed history taking, and physical examination. Standardized
histopathological examination of intraoperatively sampled
“synovial-like interface membrane” (SLIM), a term summarizing
synovial tissue and the periprosthetic membrane, has become a
beneficial tool for determining the causes of implant failure (12).
Based on histological and histochemical criteria, the expanded
SLIM consensus classification differentiates the following
patterns of adverse local tissue reactions to implant materials
(12): Wear-induced synovitis/SLIM (type I), infection-induced
synovitis/SLIM (type II), mixed synovitis/SLIM (type III),
indifferent (i.e., not wear-induced, not infection-induced)
synovitis/SLIM (type IV), prosthesis-associated arthrofibrosis
(type V), adverse local tissue reactions to implant wear particles
(type VI), and local osseous pathologies (type VII). SLIM
type VI includes inflammatory reactions secondary to wear
particle toxicity or host immunological hypersensitivity. This
SLIM type has been found to comprise three histological
patterns: (1) a predominantly macrophagic pattern with absent
or minimal lymphocytic response; (2) a mixed inflammatory
pattern, macrophagic and lymphocytic, with variable presence of
plasma cells, eosinophils, and mast cells and (3) a granulomatous
pattern, predominant, or associated with themixed inflammatory
pattern. In orthopedics, T cells infiltrating the tissue around the
implant (32) are an indicator to visualize a DTH histologically.
Yet, clinicians find it challenging to distinguish this from a
low-grade infection. In theory the cutaneous mechanism of DTH
is likely to also occur in the peri-implant tissue. The existence
of DTH toward implants is being discussed controversially
among researchers and physicians, but the demographics of
the arthroplasty clientele are shifting toward younger, more
active patients (33–35), in whom allergies have shown to be
much more prevalent than in today’s elderly (36, 37). So-called
hypoallergenic implants, which are characterized by coating
of the common metal components with inert metal-oxides
or -nitrides, are treatment options for patients with known
metal allergies. However, these implants have not reach overall
acceptance in a clinical setup and are infrequently used. Hence
reliable registry data regarding implant surveillance are pending
and evidence that hypoallergenic implants actually lead to less
prevalent metal-associated problems remains controversial.
“Metal implant allergies” potentially promote aseptic loosening
and deserve attention.
METAL EXPOSURE IN PERI-IMPLANT
BONE MARROW
Hip replacement is the surgery of the century, allergy the topic
of the decade and cobalt the allergen of the year 2016 (38). In
hip and knee arthroplasty, metallic components are fixed in the
acetabular bone and the femoral shaft, and the tibial plateau
and shaft and the femoral shaft, respectively. Primary fixation
is achieved by either a tight press-fit of the implant into the
bone or by the use of bone cement. Thus, a direct contact of
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BM and implant components early on is inevitable and direct
metal exposure of peri-implant BM cells is possible even prior to
a foreign body reaction and consequent encapsulation through
a collagen-rich synovial-like interface membrane (12). Moreover,
the dissolution of metals within the peri-implant membrane was
demonstrated by detection of these metals in the non-particulate
state (39–41). The benefit of the cobalt-chromium-molybdenum
(CoCrMo) alloy has been challenged due to the release of Co
and Cr ions and particles and associated local and systemic
adverse effects (42, 43). This alloy contains up to 1 wt% of nickel,
which can also be detected systemically increased in the case
of local metal release (44, 45). Notably, non-particulate metals
have also been detected beyond the peri-implant membrane,
in the adjacent BM of hip endoprostheses (39, 40, 46). This
suggests relevant BM exposure which potentially leads to host
responses in this multicellular tissue. Local immune reactions
and resulting inflammatory processes have widely been described
for the peri-implant membrane (47, 48). The direct contact
between BM and implant as well as the permeability of the peri-
implant membrane demand the reconsideration of (pre-)clinical
testing of implantmaterials with regard to redefinition of relevant
exposure sites (49).
ADDING UP THE PIECES
Literature on hypersensitivity reactions to orthopedic implants
is largely limited to case reports and reviews well-summarizing
clinical observations. In the meantime basic research is lacking or
focusing on different aspects, such as identifying cell signatures
and biomarkers for regeneration (50, 51). Adding up the
pieces of the newly described function of the BM and T cell
memory in light of implant associated aseptic complications,
prevalence of allergies on the rise and changing demographics
of arthroplasty patients could open up a new research field: the
allergic bone marrow.
To begin with, the implant is brought in close contact with BM
composed of immature and mature immune cells. Even months
and years after surgery, lymphocytes present beyond the peri-
implant membrane infiltrate the peri-implant tissues (52, 53).
As mentioned earlier, T cells present in the BM may drive a
hypersensitivity reaction via three imaginable mechanisms: (1)
Hypersensitivities can be developed in the periphery through
the same mechanism as in cutaneous sensitization: APCs
transport and present potential implant-derived allergens to
T cells in the proximal lymph nodes (Figure 1A). In line
with this assumption are the results of post-mortem studies,
showing significant amounts of metal debris in lymph nodes
of patients with endoprostheses (46, 54). (2) Hypersensitivities
could develop locally, where naïve T cells are primed by metal-
hapten complexes and subsequently drive a directed immune
response (Figure 1B). Even though there are no systematic
investigations evaluating whether or not the exposure to implant-
derived metal ions and particles leads to T cell priming by local
APCs in the BM, recent studies indicate that the BM could act
as a priming site for T cells (2, 19). Independent of peripheral or
local sensitization, T cells are activated, and clonally expand and
migrate to the reaction site and further drive inflammation upon
chronic exposure. Another mechanism could be (3) mediated
by T cells having already been primed in the periphery by an
allergen, such as cobalt or nickel, prior to arthroplasty surgery.
These cells home to the BM and become reactivated once
implant debris occurs in the peri-implant tissue (55) (Figure 1C).
Although only few studies show a correlation between higher
implant revision rates and preoperative sensitization (56, 57), the
prognostic value of pre-implantational cutaneous (patch test) or
systemic (LTT) metal allergy testing for implant failure is still
controversial (8).
Whether one of the proposed pathomechanisms or a
combination thereof is driving the induction of a DTH
reaction in the BM remains elusive and prompts for systematic
investigation. Yet, the prevalence of cutaneous metal sensitivity
was reported to be higher in patients with an artificial joint
as compared to the general population (58). In addition,
early osteolysis in a patient cohort with metal-on-metal hip
replacement was positively correlated with cutaneous metal
allergy (59). There is evidence that pro-inflammatory factors
released during a DTH reaction, such as Il-1, IL-2, IL-6, INF-γ,
and TNF along with subsequent activation of the NF-κB signaling
pathway promote a distorted inflammatory environment which
could enhance osteoclast activity and inhibit osteoblast function
(60, 61). This imbalance is typical for osteolysis and promotes
implant loosening (62). Depending on the strength of a cellular
response to the antigen the respective time frame may vary
from weeks to years, with only some patients showing severe
allergic reactions (31). Allergies and hypersensitivity are highly
individual processes and depend on multiple factors (Figure 2).
Based on the evidence for the immune-modulating function of
BM (6) and the higher prevalence of metal-related allergy in
patients with endoprostheses, it is reasonable to presume that
hypersensitivity reactions could occur in peri-implant tissues.
There seems to be an unmet clinical need for the development
of a more accurate bedside diagnostic assay incorporating
the potential differences between the composition of BM and
peripheral blood. Such a hypersensitivity test has to be cost-
effective, but above all must be rapid and easy to perform
before or during surgery. Several scenarios for an effective
test are conceivable: The current LTT principle for whole
blood could be applied to BM cells obtained intraoperatively
or, ideally, preoperatively from a patient’s biopsy. Even more
valuable would be a specific cellular or molecular biomarker
as a determinator of possible hypersensitivity. Other tests than
the LTT have been proposed, such as a cytokine ELIspot (63)
which is faster compared to the LTT and easier to handle.
Due to the assay time of up to 48 h such tests are currently
not a realistic option for intraoperative application and would
be limited to pre-operative use. It also remains to be clarified
which cytokines in the BM are reliable markers for the diagnosis
of DTH. The identification of such cellular or molecular
biomarkers does not only require a thorough characterization
of the BM and the peri-implant microenvironment, but also a
mechanistic understanding of the causal relationship between
the biomarker and the clinical outcome. To advance our
mechanistic understanding of DTH in BM, basic research should
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FIGURE 1 | Sensitization could occur through three potential mechanisms. It is important to note that sensitization could occur prior to or after primary implantation.
(A) Peripheral sensitization: antigen-presenting cells (APC) recognize and transport potential metal allergens derived from implant debris to the proximal lymph nodes
where they present the antigen to naïve T cells. In case of recognition the T cell gets activated, clonally expands, and is recruited to the implant site in the bone
marrow (BM). While effector T cells drive a pro-inflammatory response and recruit other cells, memory T cells are also formed and can be activated during secondary
antigen encounter. (B) Murine BM can prime naïve T cells, and drive the same immune response as described in 1a only locally, without the need of leaving the BM.
Since the BM could act as a secondary lymphoid organ, the naïve T cells could be primed by the present APCs, mature and clonally expand and also produce
memory T cells which can be activated upon second exposure. (C) T cells were primed and sensitized through an exogenous antigen before primary arthroplasty. As
described in (A,B) this produces T cell subsets including memory T cells. These could home to the BM, reside there and even remain undetected in allergy
diagnostics. Once local T cells are re-exposed to implant material reassembling the antigen, the memory T cells previously sensitized with the antigen clonally expand
again and drive an inflammatory response.
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FIGURE 2 | Implant-related hypersensitivity is influenced by multiple factors. Delayed type hypersensitivity (DTH) reactions to implant materials cannot be attributed to
a single cause. Multiple factors influence the development and consequence of hypersensitivity, many of which are yet to be identified. Bone marrow, as a T cell
harboring, possibly secondary lymphoid tissue, has the potential to develop DTH reactions when exposed to implant materials. In addition, today’s arthroplasty cohort
is younger, more active and thus more demanding with regard to implant longevity, and apparently more prone to allergies than the previous generation of implant
carriers. These include allergies against nickel and cobalt, metals that have shown to be frequently present in the proximity of endoprostheses at the time of
revision surgery.
include ex vivo analyses of patient samples and be combined
with advanced in vitro models, allowing the investigation of
implant-related aseptic inflammatory reactions in a human
biomimetic environment.
CONCLUDING REMARKS
Allergies are a trending topic not only in the broad media but
also in the clinic and in basic research. Allergy-related health
care costs and the burden on patients suffering from any kind
of overreaction of the immune system are already profound.
This trend will not stop at implant-related pathomechanisms.
While there are many excellent reviews on the topic of metal
hypersensitivity toward implant-related materials, we would
like to stress the importance of new findings on human BM
and its capacity to maintain mature lymphocytes and drive
immune responses in regard to the potential of existing implant-
related DTH. The presented mechanisms potentially underlying
the development of hypersensitivity are meant as suggestions
and to raise awareness regarding aseptic loosening and other
complications in arthroplasty being possibly rooted in reactions
induced by resident BM cells surrounding the implant. The
fact that memory T cells preferentially locate in the BM niche
could shed new light on an old debate and might spark new
research ideas and diagnostic approaches, supporting clinicians
in their decision-making.
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